BRCA1-deficient breast tumours often present as difficult to treat triple negative breast cancers (TNBC) not dissimilar to the basal-like molecular subtype of breast cancer, which lack expression of hormone receptors and easy to target growth signals. The gene discussed is BRCA1; the disease is breast carcinoma.